Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -11.36
- Piotroski Score 4.00
- Grade Buy
- Symbol (BNOX)
- Company Bionomics Limited
- Price $0.32
- Changes Percentage (7.41%)
- Change $0.02
- Day Low $0.25
- Day High $0.32
- Year High $2.19
Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has completed phase 2 clinical trial for the treatment of social anxiety disorder and post-traumatic stress disorder. It also develops BNC375, a small molecule therapeutics for the treatment of cognitive impairment in Alzheimer's disease; BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, a vascular disrupting agent, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer, and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. Bionomics Limited has a licensing agreement with Merck & Co., Inc. The company was incorporated in 1996 and is based in Eastwood, Australia.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/20/2025
- Fiscal Year End N/A
- Average Stock Price Target $6.00
- High Stock Price Target $6.00
- Low Stock Price Target $6.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$2.05
- Trailing P/E Ratio -0.35
- Forward P/E Ratio -0.35
- P/E Growth -0.35
- Net Income $-15,492,166,000
Income Statement
Quarterly
Annual
Latest News of BNOX
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Obnoxious YouTubers, little privacy and all-you-can-eat lobster -...
Around 650 travelers embarked on a nine-month Royal Caribbean Ultimate World Cruise, visiting 150 destinations. The voyage had its ups and downs, including deaths at sea, delays, and mixed feelings ab...
By New York Post | 2 months ago -
Bill Maher slams far left 'obnoxious posers' for attacking Cheryl...
Bill Maher criticized liberals for attacking Cheryl Hines for supporting her husband, Robert F. Kennedy Jr., despite his endorsement of Trump. Maher condemned the bullying and ugliness displayed by le...
By New York Post | 2 months ago -
Why VCs love obnoxious founders
The story highlights the shift in the Forbes 400 list towards self-made individuals over inherited wealth. It emphasizes the role of risk-taking and adversity in achieving extreme wealth, contrasting ...
By Business Insider | 3 months ago
